Hansoh Pharmaceutical Group dividend and valuation

3692 · HKEX · HKD

Compare Hansoh Pharmaceutical Group
$32.42Change from previous close: −2.99%Absolute change: −$1.00

Close · November 18, 2026

Valuation

Hansoh Pharmaceutical Group paid $0.49 per share in dividends over the last 12 months (yield 1.5%). Last ex-dividend date: September 22, 2026. The P/E ratio is 27.6. The average price target of 23 analysts is $48.44.

Data as of November 17, 2026

Hansoh Pharmaceutical Group compared with similar companies

Hansoh Pharmaceutical Group's P/E (trailing 12 months): 27.6, −23% against the median of a group of 11 similar companies (35.9).

Hansoh Pharmaceutical Group's metrics compared with similar companies
MetricHansoh Pharmaceutical GroupMedian25th–75th percentileBand
P/E (trailing 12 months)27.635.923.5 – 69.1Middle
Forward P/E24.829.620.9 – 41.5Middle
EV/EBITDA26.926.917.8 – 43.4Middle
Price/book4.574.743.41 – 11.4Middle
Price/sales12.79.714.11 – 14.7Middle
Gross margin90.5%75.9%61.9% – 84.0%High
Operating margin37.3%27.4%22.7% – 33.9%High
Net margin42.0%27.0%15.5% – 33.2%High
ROE19.4%15.7%14.3% – 20.7%Middle
Debt/equity0.110.110.02 – 0.41Middle

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Other metrics

Valuation multiples

Market cap
$202.62B
Enterprise value
$169.47B
PEG
2.22
EV/revenue
10.7

Profitability and growth

ROA
9.1%
ROIC
109.0%
Revenue growth (year over year)
11.7%
Earnings growth (year over year)
33.2%

Financial health

Total cash
$37.38B
Total debt
$4.23B
Current ratio
4.88
Quick ratio
4.78
Altman Z-Score
15.5
Piotroski F-Score
3.00

Dividends

Annual dividend per share
$0.49
Dividend yield
1.5%
Payout ratio
40.1%
Ex-dividend date
September 22, 2026

Analysts and estimates

Average price target
$48.44
Median price target
$48.83
High price target
$55.50
Low price target
$43.02
Analysts with a price target
23
Consensus
Strong buy
Forward EPS
$1.35
EPS estimate, current year
$1.08

Shares and trading

Beta
0.54
Average volume
10.95M
Shares outstanding
6.06B
Float
1.25B
Institutional ownership
12.8%
Insider ownership
79.6%